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There are seven coronaviruses of which four are relatively mild. The three acute 
ones are: SARS (Severe Acute Respiratory Syndrome); MERS  (Middle East 
Respiratory Syndrome; and the one causing the current pandemic, SARS-Covid-2, 
which is the technical name for the new virus. The illness caused by SARS-Covid-
2 is Covid-19. 
Many Covid-19 survivors who have been seriously ill are likely to need ongoing 
help. We know that several body systems can be affected by Covid-19, including 
the respiratory, circulatory, and digestive systems. Central nervous system 
involvement has also been documented. In some cases the virus can directly 
affect the brain, with both infection and inflammation-based mechanisms 
possible, and a range of secondary neurological effects as part of broader 
systemic illness have also been reported. As a result, alongside well-
acknowledged difficulties with fatigue and deconditioning, people recovering 
from Covid-19 may have cognitive, emotional and behavioural problems that 
require a referral to neuropsychology and/or neuropsychiatry services. We do 
not yet know how many people are affected nor how long their problems will 
last, but a number of reviews based on the early studies of people with Covid-19, 
as well as related conditions, have provided some initial pointers. 
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Within the UK, cases of those with Covid-19 admitted to hospital and presenting 
with neurological and neuropsychiatric features have been carefully profiled as 
part of the Coronerve national registry study.  Varatharaj et al. (2020) reported 
that of 153 cases submitted to the Coronerve registry, 125 had complete data. Of 
these 125, they identified that 62% had suffered a cerebrovascular event and of 
these, 74% were ischemic, 12% haemorrhagic, 1% had vasculitis and the 
remainder other cerebrovascular events. Of the 125, 31% presented with altered 
mental status, and of this subgroup, encephalitis was identified in 18%, 
unspecified encephalopathy in 23% and neuropsychiatric disorder in 59%. Of 
the 23 cases classified as neuropsychiatric, 43% were described as having 
psychosis, 26% neurocognitive disorder, and 30% other psychiatric disorders. 
Finally, 5% of the total were classified as having a peripheral disorder and 2% 
other neurological disorder. ]   
Considering the international as well as UK data, Ellul et al (2020a) examined 
case reports and series totalling 901 patients with neurological manifestations of 
Covid-19 up to May 2020, They report that cerebrovascular events have been 
unexpectedly common, being reported in 96 patients. They also highlighted that 
encephalopathy is relatively common, being reported for 93 patients in total. 
This figure includes 16 (7.5%) of 214 hospitalised COVID-19 patients in Wuhan, 
China, and 40 (69%) of 58 in intensive care with COVID-19 in France. 
Encephalitis has been documented in eight patients, and Guillain-Barré 
syndrome in 19 patients. It is important to note that there is some doubt 
regarding whether or not Covid-19 was a causal factor in all of these cases and 
some case reports have provided insufficient detail to establish causality (see 
Ellul et al., 2020b for guidance). Nonetheless, it is clear that ‘neuro-covid’ cases 
exist and appropriate care and rehabilitation pathways are needed for these 
patients.  
A recent review by Ritchie, Chan and Watermeyer (2020) is informative in 
considering the broader neuropsychological aspects of Covid-19. They cite a 
preliminary study documenting that 70% of people with Covid-19 admitted to 
intensive treatment units required mechanical ventilation, and link this to the 
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literature on cognition in acute respiratory distress syndrome (ARDS). They 
summarise that up to 78% of people with ARDS had cognitive problems a year 
post-discharge and approximately 50% at two years. Self-reported everyday 
memory failures, such as forgetting medication and appointments, have been 
found to persist in patients 5 years post-discharge. Furthermore, a proportion of 
those who have spent time in intensive care (a population that overlaps with 
ARDS) are known to experience lasting cognitive impairment. For example 
Wolters et al. (2013) found in a systematic review of the literature that, although 
estimated prevalence of cognitive impairment varied between 4-62% in patients 
followed up at between 2-156 months, the majority of studies have identified 
that critical illness and associated treatment is linked with lasting cognitive 
deficits.  Together, these findings suggest that enduring cognitive deficits are 
likely to be common in people who have had severe forms of Covid-19 even 
without an obvious neurological presentation in the acute stages. 
It is, of course, also the case that some people with pre-existing neurological 
conditions have become unwell with Covid-19, and there are indications that 
comorbidities may lead to more severe forms of the illness (e.g. Louapre et al., 
2020, found this pattern in people with multiple sclerosis). Though cognitive 
outcomes in such groups have not, to our knowledge, been studied our clinical 
impression is that cognition has been vulnerable to accelerated decline in such 
cases at least in the early stages of recovery.
We do not yet have a good understanding of the profile of cognitive deficits 
resulting from Covid-19. The studies previously cited suggest problems with 
memory, attention and information processing, and executive function, are likely 
to be particularly prevalent (e.g. based on the hypothesized sensitivity of the 
hippocampus to the virus, and the ARDS and critical illness literature).  However, 
it follows from the wide variety of neurological and neuropsychiatric 
presentations reported that the cognitive profiles are also likely to be diverse 
and as neuropsychologists we must be alert to the possibility that rare and/or 
difficult to identify syndromes may result. An Indian colleague, Jwala Narayanan, 
has reported a 62 year old patient who developed Covid-19, then had a stroke 
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and was left with Balint’s Syndrome (Narayanan, Wilson & Evans, in press). As 
far as we are aware, this is the first case of this rare syndrome to be reported in a 
patient diagnosed with Covid-19.
The mental health impacts of Covid-19 can also be estimated to be high, based on 
knowledge accrued from the earlier pandemics, and the literature on recovering 
from critical illness. Ritchie et al. (2020) cite research on psychological distress 
in MERS and SARS, identifying that up to 70% of people with confirmed MERS 
showed psychiatric symptoms including psychosis and hallucinations during 
their admission, and that in a study of 90 people with SARS, 59% were diagnosed 
with a psychiatric disorder, which persisted in a third of cases 2-3 years after the 
illness. A report by the British Psychological Society (BPS) has also emphasized 
the potential for ongoing difficulties with mood, anxiety, and fatigue likely to be 
experienced be people recovering from less severe cases of Covid-19, for 
example those hospitalized but not in intensive care (BPS, 2020), and by 
extension these may be experienced at a lower rate but by a higher number of 
people who were unwell but were not hospitalised. Family members and carers 
may also experience anxiety, stress, and problems with mood and sleep, and 
these could well be exacerbated by restrictions on visiting family members in 
hospital.
Strokes are not uncommon (Goldberg 2020). Indeed, Covid-19 may even present 
as stroke as reported in four patients in the USA (Avula et al., in press). The 
Varatharaj et al. paper referred to above found that cerebrovascular events 
predominated in patients over 50 years of age. Altered mental status, despite 
being present in all ages and most frequently reported in those in their 70s, had 
a disproportionate representation relative to cerebrovascular events in the 
young.
All of the above reports and observations suggest that many survivors of Covid-
19 are likely to require neuropsychological assessment and rehabilitation. At 
present, rehabilitation is severely underfunded. A paper from the British Society 
of Rehabilitation Medicine (BSRM: Phillips. Turner-Stokes, Wade and Walton 
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2020) stresses that rehabilitation is critical but we should expect problems when 
trying to offer this rehabilitation, as Covid-19 patients will provide a great 
challenge to the existing structures of rehabilitation.  For example, many Covid-
19 patients will need local, community-based rehabilitation services which are 
weak and often transient. If any funding is available for rehabilitation it is likely 
to go to those critically ill probably representing only  a small minority of all 
patients needing rehabilitation. 
The BSRM report touches on clinical psychology/neuropsychology when 
discussing the importance of multidisciplinary teams but it does not recognize 
the importance of neuropsychiatry and clinical psychology in relation to the 
management of the mental health needs of these patients or stress the 
importance of clinical neuropsychology when dealing with the cognitive issues, 
which is our main area of expertise. In particular, the organization of services 
around diagnoses has resulted in some Covid-19 patients who exhibit cognitive 
deficits being unfairly restricted from accessing community neurorehabilitation 
services because they do not have a formal neurological diagnosis. Furthermore 
the physical rehabilitation teams, which Covid-19 patients are referred to, are 
typically unskilled in the management of cognitive deficits.  Covid-19 has 
challenged all health care providers, including rehabilitation, and will continue to 
do so for at least the next few years. It has precipitated rapid change and 
adaptation to different circumstances. We might, in the long term develop a 
much needed change in the attention paid to rehabilitation, leading to a better 
organisation and system of funding to allow for more efficient and effective use 
of resources around need rather than diagnosis.  Such a change will benefit all 
patients and all parts of healthcare.
In the interim many patients are likely to require rehabilitation and there needs 
to be recognition by health care provides that Covid-19 patients need to be 
allowed to access services based on clinical need rather than diagnosis, as the 
long-term sequelae of the condition are still unknown. We need to provide long-
term follow up with regard to neuropsychology, as we do not know how long the 
cognitive, behavioural and emotional problems will last. 
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In June, a report from Public Health England identified that people from Black 
Asian and Minority Ethnic backgrounds are up to twice as likely to die from 
Covid-19 as people from White British background (Public Health England, 
2020), a pattern that had been increasingly apparent in news reports on those 
affected. Though the reasons behind this devastating health inequality are 
complex and remain under investigation, it is notable that the literature on 
neuropsychological aspects of Covid-19 has yet to address this issue, and it will 
be important to ensure neuropsychological procedures and services are 
culturally-informed and that their equity is monitored. This is particularly 
pressing given the contemporaneous increase in awareness of the shameful 
extent to which racism continues to exist and operate from individual through to 
societal levels worldwide, highlighted by the Black Lives Matter movement in 
response to the murder of George Floyd.
At St George’s hospital in London, we are carrying out cognitive and 
psychological screening assessments on all post Covid-19 patients referred to 
the clinical neuropsychology and clinical health psychology department. We are 
conducting this audit in an attempt to characterise the neuropsychological needs 
of the people with Covid-19 seen within our department.  We want to know the 
reasons they are referred, what type of cognitive, emotional and behavioural 
difficulties they face and what are the functional consequences of these 
problems. We also wish to discover if these difficulties persist or resolve over 
time. Through this audit we hope to be able to better understand the needs of 
this patient group, to inform the service we provide for them, and to share this 
knowledge with colleagues and commissioners. 
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